Navigation Links
Linagliptin Demonstrated Significant HbA1c Reduction in Elderly People With Type 2 Diabetes With Inadequate Glycemic Control
Date:8/15/2013

liance in the field of diabetes that centers on three compounds representing several of the largest diabetes treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about $19.1 billion (14.7 billion euro). R&D expenditure in the business are
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
2. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
3. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
4. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
7. Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
8. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
9. Groundbreaking UK Study Confirms Significant Reduction in Hospital Superbug Pathogens with TRU-D SmartUVC Disinfection Robot
10. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
11. Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, will host ... March 12, 2015, beginning at 3:00 pm Central ... Minnetonka , Minnesota.     Rob ... host the meeting, which will feature a discussion ...
(Date:3/3/2015)... March 3, 2015 Although lung cancer is ... there are only 18 drugs in the market for ... Avastin are nearing their patent expiry in 2015 and ... offers vast potential that drug manufacturers are vying to ... small cell lung cancer (SCLC) and non-small cell lung ...
(Date:3/3/2015)... March 3, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... , Chief Executive Officer of ImmunoCellular, will present a ... Annual ROTH Conference on Tuesday, March 10, 2014 ... Laguna Niguel , CA.   ... presentation, please log on through a link located in ...
Breaking Medicine Technology:Uroplasty to Host Investor Meeting at Corporate Headquarters 2Uroplasty to Host Investor Meeting at Corporate Headquarters 3Uroplasty to Host Investor Meeting at Corporate Headquarters 4Uroplasty to Host Investor Meeting at Corporate Headquarters 5Uroplasty to Host Investor Meeting at Corporate Headquarters 6Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2
... , CAMBRIDGE, Mass., Nov. 19 Ligon Discovery, Inc., ... drugs against high-value targets, today announced that it has ... The company will use the capital to complete its ... disease protein targets. With this investment, incTANK Ventures General ...
... , NEWPORT NEWS, Va., Nov. 19 Breast-Specific Gamma ... by two highly esteemed organizations for the fight against ... the American College of Surgeons. Both societies published articles ... for the early detection of breast cancer. , "These ...
Cached Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3
(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Jack Coats, ... that Mr. William A. Breukelman has been named to ... completed development of the first fully integrated version of ... capable of analyzing the three-dimensional motion of the heart ... comparing the analysis at 15,300 points to the motion ...
(Date:3/3/2015)... 03, 2015 Using an “intelligent,” rather ... Medicare Part D prescription drug coverage plans could save ... new University of Pittsburgh Graduate School of Public Health ... the March issue of the journal Health Affairs and ... have saved more than $5 billion in its Part ...
(Date:3/3/2015)... Miami, FL (PRWEB) March 03, 2015 ... to be an international keynote presenter at the ... at the Melbourne Convention and Exhibition Centre March ... on Wednesday, March 11, at 11 am (Melbourne ... Emotions and Interests,” will discuss making each customer’s ...
(Date:3/3/2015)... A recent study of the correlation ... and radio host Sharon Kleyne has been saying for ... water in the body – is extremely widespread ... the US population. Kleyne further believes that research will ... all disease, including aging and stroke. , ...
Breaking Medicine News(10 mins):Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3
... HealthDay Reporter , THURSDAY, Aug. 25 (HealthDay News) -- For kids, ... late and sleeping until noon: It also signals the beginning of ... Whether your child is a preschooler or a teen, some ... for parents is to know how to ease your children,s stress ...
... HealthDay Reporter , THURSDAY, Aug. 25 (HealthDay News) -- An ... finds that children,s vaccines are typically safe, with bad reactions ... problems. The IOM committee also agreed that there is ... later onset of conditions such as autism or type 1 ...
... the basis of new and effective treatments for ovarian ... and Portsmouth. The scientists are developing ... to stop cells from ovarian tumours growing. In initial ... from cancer patients. The extracts are complex mixtures ...
... 2011 -- Heart rate and blood pressure regulation may hold ... a new study by researchers at Wake Forest Baptist Medical ... as orthostatic intolerance (OI), which causes dizziness and occasional fainting ... debilitating chronic nausea in patients., "There seems to be a ...
... diagnostic imaging technique, physicians now have an objective test ... disease. Northwestern Memorial Hospital is among the first institutions ... imaging agent for assessment of movement disorders. Until now, ... forcing physicians to rely on clinical examinations to make ...
... An analysis of more than 1,000 research articles ... clearly associated with vaccines. A committee of experts ... scientific literature on possible adverse effects of vaccines found ... inflammation of the brain, and fainting -- that can ...
Cached Medicine News:Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 2Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 3Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 4Health News:Plants could pave the way for new ovarian cancer treatments 2Health News:Heart may hold key to unexplained nausea in youths 2Health News:New imaging test gives physicians better tool to diagnose Parkinson's disease 2Health News:New imaging test gives physicians better tool to diagnose Parkinson's disease 3Health News:Few health problems are caused by vaccines, IOM report finds 2Health News:Few health problems are caused by vaccines, IOM report finds 3
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... Gla protein, is a vitamin K-dependent, calcium ... of the noncollagenous bone matrix [1,2,3]. Osteocalcin ... a small amount produced by odontoblasts in ... formation, newly synthesized osteocalcin is incorporated into ...
... binding protein-2 (IGFBP-2) is one of six ... which specifically bind and modulate the actions ... of IGFBP-2 for IGF-II is estimated to ... suggesting a role in regulation of IGF-II ...
Medicine Products: